How to select a ophthalmology journal
Start with the disease, manuscript type, and readers who should use the result. A broad clinical cohort, a subspecialty surgery study, and a mechanistic visual science paper can need different journals even when all address the same eye disease.
Check audience fit explicitly across retina, glaucoma, cornea and anterior segment, imaging and AI, surgery, visual science, and population eye health.
Treat the three groups as an editorial fit shortlist, not a ranking or prediction of acceptance. Confirm the live aims, article type, and author instructions before submitting.
Manuscript type matrix
Start with the manuscript's main contribution, then compare audience and article-type fit before using journal metrics.
| Manuscript type | Prioritize | Avoid when |
|---|---|---|
| Broad clinical cohorts | Prioritize: A clinical ophthalmology readership that manages the diseases, interventions, and outcomes represented in the cohort. | Avoid when: The result is narrowly subspecialty-specific or descriptive without a conclusion that travels beyond one local practice. |
| Randomized/interventional | Prioritize: A journal reaching clinicians who can act on the intervention, with an article type suited to the trial design and reporting standard. | Avoid when: Registration, power, comparator choice, follow-up, or outcome definitions do not support the claimed practice implication. |
| Retina | Prioritize: A retinal audience aligned with the disease, imaging modality, treatment, vitreoretinal surgery, and patient outcome. | Avoid when: Retina is only a secondary subgroup or the main contribution is a general method intended for multiple subspecialties. |
| Glaucoma | Prioritize: Readers focused on glaucoma diagnosis, progression, imaging, medical treatment, surgery, and longitudinal outcomes. | Avoid when: Glaucoma is incidental to a broader imaging or population-health question. |
| Cornea/anterior segment | Prioritize: A cornea and anterior-segment audience matched to ocular surface disease, transplantation, refractive or cataract surgery, and outcomes. | Avoid when: The anterior-segment population is a convenience sample rather than the paper's central clinical audience. |
| Imaging/AI | Prioritize: Journals that reach the intended clinical or technical users and expect rigorous validation across relevant devices and populations. | Avoid when: The model lacks external validation, clinically meaningful comparison, transparent reporting, or a credible path to use. |
| Visual science/basic mechanisms | Prioritize: A mechanistic or translational readership aligned with the experimental model, visual function, ocular tissue, and biological question. | Avoid when: The study is purely descriptive or makes clinical claims without a demonstrated translational bridge. |
| Population eye health | Prioritize: Readers working in epidemiology, prevention, access, policy, health services, disparities, and implementation of eye care. | Avoid when: A local prevalence estimate or service description lacks a broader inference, comparison, or actionable eye-health implication. |
Reach journals
Consider these when the evidence is rigorous and the conclusion matters across ophthalmic practice or population eye health. A broad readership is a fit signal, not evidence of easier acceptance.
OPHTHALMOLOGY
Elsevier BV
- 2026 Impact Factor
- 10.9
- JCR quartile
- Q1
- 2025 publication volume
- 374
- Median submission-to-acceptance
- 65.5 days
- n=100 · 100% coverage
Suitable for
- • Practice-changing trials and comparative studies
- • Large clinical cohorts and outcomes research
- • Validated imaging and health-services evidence
Why it may fit
Practice-changing clinical ophthalmology, trials, large cohorts, imaging, and health-services evidence.
Caution
Broad clinical importance and rigorous validation are expected.
JAMA Ophthalmology
American Medical Association
- 2026 Impact Factor
- 10.5
- JCR quartile
- Q1
- 2025 publication volume
- 303
- Median submission-to-acceptance
- Not enough public date data
Suitable for
- • Clinically consequential eye research
- • Epidemiology and population eye health
- • Policy and evidence affecting patient care
Why it may fit
Clinically consequential eye research, epidemiology, policy, and evidence affecting patient care.
Caution
Frame the result for broad clinical and public-health relevance.
AMERICAN JOURNAL OF OPHTHALMOLOGY
Elsevier BV
- 2026 Impact Factor
- 4.7
- JCR quartile
- Q1
- 2025 publication volume
- 586
- Median submission-to-acceptance
- 100.5 days
- n=96 · 96% coverage
Suitable for
- • Retina, glaucoma, and cornea studies
- • Ophthalmic surgery and clinical outcomes
- • Clinically relevant imaging research
Why it may fit
Clinical studies across retina, glaucoma, cornea, surgery, imaging, and outcomes.
Caution
Confirm the accepted study and article type in current instructions.
- 2026 Impact Factor
- 4.5
- JCR quartile
- Q1
- 2025 publication volume
- 249
- Median submission-to-acceptance
- 152 days
- n=99 · 99% coverage
Suitable for
- • International clinical and surgical studies
- • Epidemiology and population eye health
- • Translational ophthalmology with clinical relevance
Why it may fit
International clinical, surgical, epidemiologic, and translational ophthalmology.
Caution
The conclusion should matter beyond a narrow local practice pattern.
Strong-match journals
These can be the strongest destination when a retina, visual science, clinical-translational, or data-driven readership matches the paper more precisely. A focused scope is not an easier acceptance path.
Ophthalmology Retina
Elsevier BV
- 2026 Impact Factor
- 5.9
- JCR quartile
- Q1
- 2025 publication volume
- 286
- Median submission-to-acceptance
- 40 days
- n=100 · 100% coverage
Suitable for
- • Retinal disease and treatment studies
- • Retinal imaging and biomarkers
- • Vitreoretinal surgery, trials, and real-world outcomes
Why it may fit
Retinal disease, imaging, vitreoretinal surgery, trials, and real-world retina outcomes.
Caution
Retina must be the primary audience rather than a secondary analysis.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Cadmus Press
- 2026 Impact Factor
- 5.5
- JCR quartile
- Q1
- 2025 publication volume
- 834
- Median submission-to-acceptance
- Not enough public date data
Suitable for
- • Mechanisms of normal and abnormal visual function
- • Translational eye and vision research
- • Quantitative imaging and structure-function studies
Why it may fit
Mechanistic, translational, imaging, and quantitative vision research.
Caution
Purely descriptive clinical series may need a clinical journal.
- 2026 Impact Factor
- 5.1
- JCR quartile
- Q1
- 2025 publication volume
- 187
- Median submission-to-acceptance
- 127 days
- n=97 · 97% coverage
Suitable for
- • Clinical ophthalmology with practice implications
- • Translational eye research
- • Imaging and experimental findings linked to patient care
Why it may fit
Clinical and translational eye research with clear implications for ophthalmic practice.
Caution
Connect laboratory or imaging findings to the clinical audience.
Ophthalmology Science
Elsevier BV
- 2026 Impact Factor
- 5.0
- JCR quartile
- Q1
- 2025 publication volume
- 338
- Median submission-to-acceptance
- 133 days
- n=99 · 99% coverage
Suitable for
- • Preclinical development
- • Phase 1–2 clinical trials
- • Laboratory and ophthalmology informatics studies
Why it may fit
Open-access preclinical, early-phase clinical, laboratory, informatics, and data-driven ophthalmic science.
Caution
Later-phase or broadly practice-changing clinical studies may fit a more general clinical journal; verify current indexing, fees, and reporting requirements.
Broader-scope journals
These journals can fit mechanistic, technological, open clinical, or international work when their audience and article type align. Broader scope does not mean easier acceptance; evidence quality and editorial fit still matter.
EXPERIMENTAL EYE RESEARCH
Elsevier BV
- 2026 Impact Factor
- 3.1
- JCR quartile
- Q2
- 2025 publication volume
- 498
- Median submission-to-acceptance
- 109 days
- n=100 · 100% coverage
Suitable for
- • Cellular and molecular eye research
- • Ocular physiology and disease mechanisms
- • Preclinical models with mechanistic depth
Why it may fit
Cellular, molecular, physiological, and preclinical mechanisms of eye disease.
Caution
Human clinical outcome papers without mechanistic depth may not fit.
Translational Vision Science & Technology
Association for Research in Vision and Ophthalmology
- 2026 Impact Factor
- 2.7
- JCR quartile
- Q2
- 2025 publication volume
- 392
- Median submission-to-acceptance
- Not enough public date data
Suitable for
- • Ophthalmic imaging and visual technology
- • Devices and quantitative clinical tools
- • Validated AI with a path to clinical application
Why it may fit
Visual technology, imaging, devices, AI, and translation toward clinical use.
Caution
Demonstrate validation and a credible path to clinical application.
- 2026 Impact Factor
- 2.7
- JCR quartile
- Q2
- 2025 publication volume
- 135
- Median submission-to-acceptance
- 143 days
- n=98 · 98% coverage
Suitable for
- • Open clinical and surgical ophthalmology
- • Epidemiology and population eye health
- • Health-services and implementation research
Why it may fit
Open clinical, epidemiologic, surgical, and health-services eye research.
Caution
Open access and publication volume do not imply easier acceptance.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Springer Science+Business Media
- 2026 Impact Factor
- 2.8
- JCR quartile
- Q2
- 2025 publication volume
- 337
- Median submission-to-acceptance
- 139 days
- n=100 · 100% coverage
Suitable for
- • Clinical ophthalmology across subspecialties
- • Clinically relevant experimental research
- • International cohorts and outcomes studies
Why it may fit
Broad clinical and experimental ophthalmology across subspecialties.
Caution
Show why the result matters to an international ophthalmic readership.
Journals receiving a first JIF in 2026
Explore newer metric entrants separately, then return to manuscript fit when building the final submission shortlist.
See the ophthalmology first-JIF analysis →Test the shortlist against your research
Compare manuscript fit with AI or examine the literature around your research topic in PubMed.
Methodology and limits
Broader-scope does not mean easy acceptance. There is no comprehensive acceptance-rate data for these journals, and the metrics on this page do not predict acceptance.
Publication volume uses OpenAlex works from the complete 2025 calendar year. OpenAlex works are not submissions or acceptances, so output describes publishing scale rather than editorial selectivity.
Timing uses qualified PubMed received-to-accepted date pairs from the fixed 2024–2025 window. It is a historical median, not a forecast. Missing date data is not evidence of speed, and unqualified journals are shown as “Not enough public date data.”
Confirm each journal's current scope, article types, author instructions, indexing, fees, and policies before submission.
Frequently asked questions
Should I choose a general ophthalmology journal or a subspecialty journal?
Choose the audience that most needs the result. A general journal can suit evidence with broad clinical or public-health implications, while a subspecialty journal is often the better match when the disease, procedure, imaging method, and practical implications are concentrated in retina, glaucoma, cornea, or another focused practice.
Does higher publication volume mean a journal is easier to enter?
No. The 2025 OpenAlex publication volume describes recent output, not an acceptance rate or editorial threshold. Use it to understand publishing scale only, then evaluate scope, article type, evidence quality, and audience fit.
What does the PubMed submission-to-acceptance timing mean?
The timing is a median calculated only for journals with qualified coverage of paired received and accepted dates in PubMed records. It is descriptive historical context, not a promise for a new submission or a substitute for the journal's current guidance.
How does the first-JIF analysis complement this guide?
The linked first-JIF analysis examines ophthalmology journals receiving a first Journal Impact Factor in the 2026 release. Use it to explore newer metric entrants, then return here to compare established shortlist options by manuscript fit.
Related Articles
Best Neurosurgery Journals 2026: IF, Volume & Timing
Compare neurosurgery journals by Impact Factor 2026, 2025 publication volume, submission-to-acceptance timing, and manuscript fit.
16 min readJournal Submission GuideBest Bioinformatics Journals 2026: IF, Volume & Timing
Compare bioinformatics journals by Impact Factor 2026, 2025 publication volume, submission-to-acceptance timing, and manuscript fit.
16 min readJournal Submission GuideBest Pediatrics Journals 2026: IF, Volume & Timing
Compare pediatrics journals by Impact Factor 2026, 2025 publication volume, submission-to-acceptance timing, and manuscript fit.
16 min readTake the next research step
Compare manuscript fit with AI or examine the literature around your research topic in PubMed.
Canonical article: https://www.journalmetrics.org/blog/best-ophthalmology-journals